J&J reaches agreement with U.S. government on access to medicines

Johnson & Johnson announced a voluntary agreement with the U.S. government to expand access to medicines and secure a tariff exemption for its pharmaceutical products; the company also outlined new U.S. manufacturing facilities as part of a broader investment to support domestic production.

Johnson & Johnson announced a voluntary agreement with the U.S. government intended to improve access to medicines and lower costs for American patients. The company said the pact meets requests from President Trump and includes an exemption from tariffs on its pharmaceutical products. J&J reported it will participate in TrumpRx.gov, a direct-to-patient platform, and said it will align patient and Medicaid pricing with comparable developed countries. The company also described plans for two new U.S. manufacturing facilities as part of a larger investment to support domestic production. Key details: - The agreement is reported as aimed at improving access to medicines and lowering costs for millions of American patients. - The pact is described as meeting requests laid out by President Trump and includes an exemption from tariffs for the company’s pharmaceutical products. - J&J said it will participate in TrumpRx.gov and work to enable patient and Medicaid access at prices comparable to other developed countries. - The company announced two new U.S. manufacturing facilities, including a next-generation cell therapy site in Pennsylvania and a drug product facility in North Carolina. - Construction is reported as progressing on a $2 billion biologics manufacturing facility in Wilson, North Carolina, and the company said the broader investment supports advanced manufacturing hiring. Summary: The agreement is reported as aiming to expand patient access and includes a tariff exemption for J&J's pharmaceutical products. The company also announced new manufacturing sites in Pennsylvania and North Carolina and noted ongoing construction of a biologics facility in Wilson, North Carolina. Undetermined at this time.